Search Results - "Heinemann, L"

New ways of insulin delivery by Heinemann, L

“…The predominant number of papers published from the middle of 2009 to the middle of 2010 about alternative routes of insulin administration (ARIA) were still…”
Get full text

Benchtop isolation and characterization of functional exosomes by sequential filtration by Heinemann, Mitja L., Ilmer, Matthias, Silva, Leslie P., Hawke, David H., Recio, Alejandro, Vorontsova, Maria A., Alt, Eckhard, Vykoukal, Jody

“…•We developed a novel method for isolation of exosomes by sequential filtration.•Exosome isolates from biofluids via the method exhibit uniform size and…”
Get full text

New ways of insulin delivery by Heinemann, L

Get full text

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study by Martin, S, Schneider, B, Heinemann, L, Lodwig, V, Kurth, H.-J, Kolb, H, Scherbaum, W. A

“…Aims/hypothesis The aim of this study was to obtain epidemiological data on self-monitoring of blood glucose (SMBG) in type 2 diabetes and to investigate the…”
Get full text

Targeted Lipidomics for Characterization of PUFAs and Eicosanoids in Extracellular Vesicles by Reinicke, Madlen, Shamkeeva, Saikal, Hell, Max, Isermann, Berend, Ceglarek, Uta, Heinemann, Mitja L

“…Lipids are increasingly recognized as bioactive mediators of extracellular vesicle (EV) functions. However, while EV proteins and nucleic acids are well…”
Get full text

Continuous glucose monitoring: quality of hypoglycaemia detection by Zijlstra, E., Heise, T., Nosek, L., Heinemann, L., Heckermann, S.

“…Aims To evaluate the accuracy of a (widely used) continuous glucose monitoring (CGM)‐system and its ability to detect hypoglycaemic events. Methods A total of…”
Get full text

Biosimilar insulins: guidance for data interpretation by clinicians and users by Heinemann, L., Home, P. D., Hompesch, M.

“…Biosimilar insulins are approved copies of insulins outside patent protection. Advantages may include greater market competition and potential cost reduction,…”
Get full text

Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy—an emerging problem and solutions offered by diabetes technology by Pfützner, A., Klonoff, D., Heinemann, L., Ejskjaer, N., Pickup, J.

“…Diabetic ketoacidosis is an infrequent but life-threatening acute complication of diabetes, affecting predominantly patients with type 1 diabetes, children,…”
Get full text

Evidence for continuous glucose monitoring: sufficient for reimbursement? by Heinemann, L., DeVries, J. H.

“…Evidence for continuous glucose monitoring is mounting. Meta‐analyses consistently show lowering of HbA1c, and the first trial reporting a reduction in severe…”
Get full text

Biosimilar insulins: a European perspective by DeVries, J. H., Gough, S. C. L., Kiljanski, J., Heinemann, L.

“…Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the…”
Get full text

Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study by Doerr, R., Hoffmann, U., Otter, W., Heinemann, L., Hunger-Battefeld, W., Kulzer, B., Klinge, A., Lodwig, V., Amann-Zalan, I., Sturm, D., Tschoepe, D., Spitzer, S. G., Stumpf, J., Lohmann, T., Schnell, O.

“…Aims/hypothesis The primary aim of this study was to compare the results of HbA 1c measurements with those of an OGTT for early diagnosis of ‘silent diabetes’…”
Get full text

Sensors for glucose monitoring: technical and clinical aspects by Koschinsky, T., Heinemann, L.

“…The aim of this article is to critically discuss the technical and clinical aspects of glucose sensors and to briefly review current technical developments…”
Get full text

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine by Nel, Ivonne, Münch, Carolin, Shamkeeva, Saikal, Heinemann, Mitja L, Isermann, Berend, Aktas, Bahriye

“…The "Liquid Biopsy" has become a powerful tool for cancer research during the last decade. Circulating cell-free DNA (cfDNA) that originates from tumors has…”
Get full text

New ways of insulin delivery by Heinemann, L

“…When Exubera (EXU), the first inhaled insulin formulation to make it through the clinical development process, was introduced to the market some years ago it…”
Get full text

First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system by Caduff, A, Hirt, E, Feldman, Yu, Ali, Z, Heinemann, L

“…This paper describes a non-invasive continuous glucose monitoring system based on impedance spectroscopy. Changes in the glucose concentrations can be…”
Get full text

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial by White, C L, Twigger, K R, Vidal, L, De Bono, J S, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, R G, Melcher, A A, Pandha, H S, Harrington, K J

“…There is an emerging realization from animal models that the immune response may have both detrimental and beneficial therapeutic effects during cancer…”
Get full text

Non-invasive glucose monitoring in patients with diabetes: A novel system based on impedance spectroscopy by Caduff, A., Dewarrat, F., Talary, M., Stalder, G., Heinemann, L., Feldman, Yu

“…The aim of this work was to evaluate the performance of a novel non-invasive continuous glucose-monitoring system based on impedance spectroscopy (IS) in…”
Get full text

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells by Recio-Boiles, Alejandro, Ilmer, Matthias, Rhea, P Robyn, Kettlun, Claudia, Heinemann, Mitja L, Ruetering, Jennifer, Vykoukal, Jody, Alt, Eckhard

“…Successful treatment of solid cancers mandates targeting cancer stem cells (CSC) without impact on the physiology of normal tissue resident stem cells. C-Jun…”
Get full text

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo by HEINEMANN, L, LINKESCHOVA, R, RAVE, K, HOMPESCH, B, SEDLAK, M, HEISE, T

“…Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. L Heinemann , R…”
Get full text

Living with transplant by Heinemann, Laura L.

“…Organ transplantation is often held to epitomize the power and promise of biomedicine. Yet life after transplant does not so clearly mark an ‘after’ to…”
Get full text